These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20407668)

  • 1. Quantum dots decorated with pathogen associated molecular patterns as fluorescent synthetic pathogen models.
    Barr TA; Krembuszewski M; Gupta M; Gray D; Mareque-Rivas JC
    Mol Biosyst; 2010 Sep; 6(9):1572-5. PubMed ID: 20407668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes.
    Zähringer U; Salvetzki R; Wagner F; Lindner B; Ulmer AJ
    J Endotoxin Res; 2001; 7(2):133-46. PubMed ID: 11521094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a monophosphoryl derivative of Escherichia coli lipid A and its efficient coupling to a tumor-associated carbohydrate antigen.
    Tang S; Wang Q; Guo Z
    Chemistry; 2010 Jan; 16(4):1319-25. PubMed ID: 19943286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Synthesis and Immunomodulatory Functions of Bacterial Lipid As.
    Shimoyama A; Fukase K
    Methods Mol Biol; 2023; 2613():33-53. PubMed ID: 36587069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.
    Geurtsen J; Fransen F; Vandebriel RJ; Gremmer ER; de la Fonteyne-Blankestijn LJ; Kuipers B; Tommassen J; van der Ley P
    Vaccine; 2008 Feb; 26(7):899-906. PubMed ID: 18207288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics.
    Lewicky JD; Ulanova M; Jiang ZH
    Bioorg Med Chem; 2013 Apr; 21(8):2199-2209. PubMed ID: 23490149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid A structures containing novel lipid moieties: synthesis and adjuvant properties.
    Jiang ZH; Bach MV; Budzynski WA; Krantz MJ; Koganty RR; Longenecker BM
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2193-6. PubMed ID: 12127535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of splenocytes in C3H/HeJ mice with Porphyromonas gingivalis lipid A in comparison with enterobacterial lipid A.
    Ogawa T; Shimauchi H; Uchida H; Mori Y
    Immunobiology; 1996; 196(4):399-414. PubMed ID: 9061380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid A-Mediated Bacterial-Host Chemical Ecology: Synthetic Research of Bacterial Lipid As and Their Development as Adjuvants.
    Shimoyama A; Fukase K
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.
    Vasan M; Wolfert MA; Boons GJ
    Org Biomol Chem; 2007 Jul; 5(13):2087-97. PubMed ID: 17581652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining the requisite lipopolysaccharide structure in Escherichia coli.
    Meredith TC; Aggarwal P; Mamat U; Lindner B; Woodard RW
    ACS Chem Biol; 2006 Feb; 1(1):33-42. PubMed ID: 17163638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a dimeric monosaccharide lipid A mimic and its synergistic effect on the immunostimulatory activity of lipopolysaccharide.
    Lewicky JD; Ulanova M; Jiang ZH
    Carbohydr Res; 2011 Sep; 346(13):1705-13. PubMed ID: 21689810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic activity of lipopolysaccharides released from macrophages after the uptake of intact E. coli in vitro.
    Duncan RL; Hoffman J; Tesh VL; Morrison DC
    J Immunol; 1986 Apr; 136(8):2924-9. PubMed ID: 3514750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of the lipopolysaccharide of Escherichia coli 126].
    Varbanets LD; Zdorovenko EA; Brovarskaya OS; Kalinichenko SV
    Mikrobiologiia; 2017; 86(1):54-61. PubMed ID: 30207143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lipid A from Rhodopseudomonas palustris Strain BisA53 LPS Possesses a Unique Structure and Low Immunostimulant Properties.
    Di Lorenzo F; Palmigiano A; Al Bitar-Nehme S; Sturiale L; Duda KA; Gully D; Lanzetta R; Giraud E; Garozzo D; Bernardini ML; Molinaro A; Silipo A
    Chemistry; 2017 Mar; 23(15):3637-3647. PubMed ID: 28004420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical synthesis of Helicobacter pylori lipopolysaccharide partial structures and their selective proinflammatory responses.
    Shimoyama A; Saeki A; Tanimura N; Tsutsui H; Miyake K; Suda Y; Fujimoto Y; Fukase K
    Chemistry; 2011 Dec; 17(51):14464-74. PubMed ID: 22095469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction.
    Kirikae T; Schade FU; Zähringer U; Kirikae F; Brade H; Kusumoto S; Kusama T; Rietschel ET
    FEMS Immunol Med Microbiol; 1994 Jan; 8(1):13-26. PubMed ID: 8156049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1.
    Okemoto K; Kawasaki K; Hanada K; Miura M; Nishijima M
    J Immunol; 2006 Jan; 176(2):1203-8. PubMed ID: 16394010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.